PTGS2 and Insulin resistance: Improved the reduction of neurotrophic factors induced by STZ (BDNF, GDNF) and insulin resistance dysfunction, and decreased the levels of inflammatory markers, nuclear factor kappa-B translocation, glial fibrillary acidic protein, cyclooxygenase-2, tumor necrosis factor-α, and oxidative-nitrosative stress.